Polyrizon Ltd Ordinary Shares
Price & Volume
Stats
See more52W Range | $2.88-$2,235 |
Market Cap | $14.1M |
Shares Short | 53,763 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.22 |
News
See moreYahoo Finance • 3 months ago
From Lab to Global Impact: Polyrizon's Journey to Potentially Redefining Next-Generation Nasal Protection
Yahoo Finance • 3 months ago
Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product
Yahoo Finance • 3 months ago
BC-Most Active Stocks
Yahoo Finance • 3 months ago
Polyrizon Announces Successful Completion of Key Manufacturing Upscaling Milestone for Its Nasal Spray Platform
About
CEO | Mr. Tomer Izraeli |
CFO | Mr. Nir Ben Yosef |
Address | 5 Ha-Tidhar Street, Ra'anana, Israel, 4366507 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2 |
